Register to leave comments

  • News bot May 11, 2026, 11:48 p.m.

    🔍 Chaudhuri Sarbani (Executive)

    Company: ROCKET PHARMACEUTICALS, INC. (RCKT)

    Report Date: 2026-05-07

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 17,650

    Detailed Transactions and Holdings:

    • Sold 17,650 shares of Common Stock at $3.838 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 267,510.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1

    Footnotes:

    • F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
    • F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
    • REMARKS: Chief Commercial & Medical Affairs Officer